Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients

Suzana Margareth Lobo, Paula F. Salgado, Vânia G. T. Castillo, Aldenis Albaneze Borim, Carlos A. Polachini, José C. Palchetti, Sergio L. A. Brienzi, Granville G. de Oliveira

Critical Care Medicine · 2000 · 508 citations · 45 references

Concepts

TL;DR

The study aimed to assess whether maximizing oxygen delivery reduces morbidity and mortality in patients over 60 or with chronic organ disease undergoing major elective surgery. In a prospective randomized controlled trial, 37 high‑risk patients were assigned to either a control group maintaining normal oxygen delivery or a protocol group targeting supranormal delivery using volume expansion and dobutamine during surgery and the first 24 h post‑op. The protocol group experienced a significantly lower 60‑day mortality (15.7 % vs 50 %) and fewer clinical and infectious complications (31 % vs 67 %) compared with controls, indicating that maximizing oxygen transport with dobutamine improves outcomes in high‑risk surgical patients.

Abstract

Objective To evaluate the effects of maximizing the oxygen delivery on morbidity and mortality in patients >60 yrs of age and/or with chronic diseases of vital organs who underwent major elective surgery. Design Prospective, randomized, controlled trial. Setting A 24-bed general intensive care unit of a teaching hospital. Patients Thirty-seven high-risk patients who underwent major surgery. Interventions The hemodynamic and oxygen transport variables and outcomes in 18 patients (control group) treated to maintain normal values of oxygen delivery were compared with 19 patients (protocol group) treated to maintain "supranormal" values. Therapy in both groups consisted of volume expansion and, when necessary, dobutamine to reach target values, during the surgery and 24 hrs postoperatively. Measurements and Main Results We interrupted the study because of a significant difference in the 60-day mortality rate. The mortality rate in the control group was significantly higher when compared with the protocol group (9/18 [50%] vs. 3/19 [15.7%], p < .05). The prevalence of clinical and infectious complications was higher in the control group than in the protocol group (67% and 31% respectively; relative risk, 0.47; 95% confidence interval, 0.226–0.991;p < .05) and there was a trend toward more severe organ dysfunction in nonachievers patients (17/24 [71%] vs. 6/13 [46%], relative risk, 0.65; 95% confidence interval, 0.343–1.237; NS). Conclusion Older patients with existing cardiorespiratory illness undergoing major surgery have a reduced morbidity and mortality when dobutamine is used to maximize oxygen transport.

References

45